Q4 2020 Holdings
Filed 2021-02-16 | 8 holdings | $706.6K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| iTeos Therapeutics, Inc.(5E7) | Common | 46565G104 | $125.4K | 3,706,663 | 17.7% |
| Tcr2 Therapeutics, Inc. | Common | 87808K106 | $125.3K | 4,050,865 | 17.7% |
| Dyne Therapeutics, Inc.(DYN) | Common | 26818M108 | $104.0K | 4,951,303 | 14.7% |
| Repare Therapeutics, Inc.(RPTX) | Common | 760273102 | $103.0K | 3,003,772 | 14.6% |
| Oncorus, Inc. | Common | 68236R103 | $92.1K | 2,849,464 | 13.0% |
| Harpoon Therapeutics, Inc. | Common | 41358P106 | $75.2K | 4,524,425 | 10.6% |
| Rhythm Pharmaceuticals, Inc.(RYTM) | Common | 76243J105 | $56.8K | 1,909,258 | 8.0% |
| Chiasma, Inc.(CHMA) | Common | 16706W102 | $25.0K | 5,736,296 | 3.5% |